Related Experiment Videos
The case for calcium antagonists as first-line treatment of hypertension
1Department of Research, University Hospitals, Kantonsspital Basel, Switzerland.
Insights
Calcium antagonists are effective first-line treatments for hypertension, especially in the elderly. They offer cardiovascular benefits beyond blood pressure reduction and do not worsen lipid or insulin resistance profiles.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Geriatrics
Background:
- Hypertension is a prevalent condition, particularly in the elderly population.
- Calcium antagonists demonstrate particular efficacy in this demographic.
- Unlike thiazides or beta-blockers, calcium antagonists do not adversely affect lipid profiles or insulin resistance.
Purpose of the Study:
- To review evidence supporting calcium antagonists as first-line hypertension treatment.
- To evaluate their favorable effects on cardiovascular risk factors beyond blood pressure reduction.
Main Methods:
- Review of existing evidence on calcium antagonists.
- Evaluation of their impact on cardiovascular risk factors.
- Assessment of their role in atherosclerosis development.
Main Results:
- Calcium antagonists show superior efficacy in the elderly hypertensive population.
- These agents positively influence cardiovascular risk factors implicated in atherosclerosis.
- They do not exhibit the negative metabolic side effects associated with other antihypertensive classes.
Conclusions:
- Calcium antagonists are the preferred choice for first-line hypertension therapy.
- Their favorable effects on atherosclerosis pathogenesis support their use.
- They are easily combined with other major antihypertensive drug classes.
Objectives:
The evidence in favour of using calcium antagonists as first-line treatment for hypertension was reviewed. Without performing a comprehensive meta-analysis, an evaluation was made of the favourable effects of these agents on cardiovascular risk factors other than the reduction in blood pressure.
Background:
Hypertension is a disease of the elderly, in whom calcium antagonists are particularly effective. These agents do not have the adverse effects on lipids or insulin resistance seen with thiazides or beta-blockers.
Mode Of Action:
Promising new data show that the development of atherosclerosis can be slowed by interference with endothelial and platelet mechanisms, inhibition of vascular smooth muscle proliferation, binding of lipoproteins and hydrolysis of cholesterol esters in liposomes.
Conclusions:
On the grounds of superior efficacy in the target patient population, together with favourable effects on other important factors in the genesis of atherosclerosis, calcium antagonists are the drugs of choice for first-line therapy and are also readily combined with the other major classes of antihypertensive drugs.